全文获取类型
收费全文 | 1741篇 |
免费 | 366篇 |
国内免费 | 3篇 |
专业分类
耳鼻咽喉 | 10篇 |
儿科学 | 94篇 |
妇产科学 | 33篇 |
基础医学 | 171篇 |
口腔科学 | 16篇 |
临床医学 | 255篇 |
内科学 | 423篇 |
皮肤病学 | 38篇 |
神经病学 | 126篇 |
特种医学 | 36篇 |
外科学 | 176篇 |
综合类 | 254篇 |
一般理论 | 1篇 |
预防医学 | 242篇 |
眼科学 | 10篇 |
药学 | 123篇 |
中国医学 | 1篇 |
肿瘤学 | 101篇 |
出版年
2023年 | 28篇 |
2022年 | 18篇 |
2021年 | 73篇 |
2020年 | 47篇 |
2019年 | 52篇 |
2018年 | 49篇 |
2017年 | 36篇 |
2016年 | 53篇 |
2015年 | 50篇 |
2014年 | 75篇 |
2013年 | 88篇 |
2012年 | 99篇 |
2011年 | 123篇 |
2010年 | 62篇 |
2009年 | 47篇 |
2008年 | 88篇 |
2007年 | 88篇 |
2006年 | 104篇 |
2005年 | 72篇 |
2004年 | 74篇 |
2003年 | 79篇 |
2002年 | 69篇 |
2001年 | 34篇 |
2000年 | 31篇 |
1999年 | 34篇 |
1998年 | 12篇 |
1997年 | 18篇 |
1996年 | 27篇 |
1995年 | 29篇 |
1994年 | 26篇 |
1993年 | 35篇 |
1992年 | 44篇 |
1991年 | 39篇 |
1990年 | 47篇 |
1989年 | 39篇 |
1988年 | 28篇 |
1987年 | 19篇 |
1986年 | 9篇 |
1985年 | 12篇 |
1984年 | 11篇 |
1983年 | 12篇 |
1981年 | 8篇 |
1980年 | 15篇 |
1979年 | 19篇 |
1978年 | 20篇 |
1977年 | 6篇 |
1975年 | 6篇 |
1974年 | 6篇 |
1971年 | 7篇 |
1966年 | 5篇 |
排序方式: 共有2110条查询结果,搜索用时 15 毫秒
71.
Alexandra?W.?Acher Malcolm?H.?Squires Ryan?C.?Fields George?A.?Poultsides Carl?Schmidt Konstantinos?I.?Votanopoulos Timothy?M.?Pawlik Linda?X.?Jin Aslam?Ejaz David?A.?Kooby Mark?Bloomston David?Worhunsky Edward?A.?Levine Neil?Saunders Emily?Winslow Clifford?S.?Cho Glen?Leverson Shishir?K.?Maithel Sharon?M.?WeberEmail author 《Journal of gastrointestinal surgery》2016,20(7):1284-1294
Background
This study utilized a multi-institutional database to evaluate risk factors for readmission in patients undergoing curative gastrectomy for gastric adenocarcinoma with the intent of describing both perioperative risk factors and the relationship of readmission to survival.Methods
Patients who underwent curative resection of gastric adenocarcinoma from 2000 to 2012 from seven academic institutions of the US Gastric Cancer Collaborative were analyzed. In-hospital deaths and palliative surgeries were excluded, and readmission was defined as within 30 days of discharge. Univariate and multivariable logistic regression analyses were employed and survival analysis conducted.Results
Of the 855 patients, 121 patients (14.2 %) were readmitted. Univariate analysis identified advanced age (p?<?0.0128), American Society of Anesthesiology status ≥3 (p?=?0.0045), preexisting cardiac disease (p?<?0.0001), hypertension (p?=?0.0142), history of smoking (p?=?0.0254), increased preoperative blood urea nitrogen (BUN; p?=?0.0426), concomitant pancreatectomy (p?=?0.0056), increased operation time (p?=?0.0384), estimated blood loss (p?=?0.0196), 25th percentile length of stay (<7 days, p?=?0.0166), 75th percentile length of stay (>12 days, p?=?0.0256), postoperative complication (p?<?0.0001), and total gastrectomy (p?=?0.0167) as risk factors for readmission. Multivariable analysis identified cardiac disease (odds ratio (OR) 2.4, 95 % confidence interval (CI) 1.6–3.3, p?<?0.0001), postoperative complication (OR 2.3, 95 % CI 1.6–5.4, p?<?0.0001), and pancreatectomy (OR 2.2, 95 % CI 1.1–4.1, p?=?0.0202) as independent risk factors for readmission. There was an association of decreased overall median survival in readmitted patients (39 months for readmitted vs. 103 months for non-readmitted). This was due to decreased survival in readmitted stage 1 (p?=?0.0039), while there was no difference in survival for other stages. Stage I readmitted patients had a higher incidence of cardiac disease than stage I non-readmitted patients (58 vs. 24 %, respectively, p?=?0.0002).Conclusions
Within this multi-institutional study investigating readmission in patients undergoing curative resection for gastric cancer, cardiac disease, postoperative complication, and concomitant pancreatectomy were identified as significant risk factors for readmission. Readmission was associated with decreased overall median survival, but on further analysis, this was driven by differences in survival for stage I disease only.72.
Laura Dwyer-Lindgren Ellen R. Squires Stephanie Teeple Gloria Ikilezi D. Allen Roberts Danny V. Colombara Sarah Katherine Allen Stanley M. Kamande Nicholas Graetz Abraham D. Flaxman Charbel El Bcheraoui Kristjana Asbjornsdottir Gilbert Asiimwe Ângelo Augusto Orvalho Augusto Baltazar Chilundo Caroline De Schacht Sarah Gimbel Carol Kamya Faith Namugaya Felix Masiye Cremildo Mauieia Yodé Miangotar Honoré Mimche Acácio Sabonete Haribondhu Sarma Kenneth Sherr Moses Simuyemba Aaron Chisha Sinyangwe Jasim Uddin Bradley H. Wagenaar Stephen S. Lim 《Population health metrics》2018,16(1):13
Background
The under-5 mortality rate (U5MR) is an important metric of child health and survival. Country-level estimates of U5MR are readily available, but efforts to estimate U5MR subnationally have been limited, in part, due to spatial misalignment of available data sources (e.g., use of different administrative levels, or as a result of historical boundary changes).Methods
We analyzed all available complete and summary birth history data in surveys and censuses in six countries (Bangladesh, Cameroon, Chad, Mozambique, Uganda, and Zambia) at the finest geographic level available in each data source. We then developed small area estimation models capable of incorporating spatially misaligned data. These small area estimation models were applied to the birth history data in order to estimate trends in U5MR from 1980 to 2015 at the second administrative level in Cameroon, Chad, Mozambique, Uganda, and Zambia and at the third administrative level in Bangladesh.Results
We found substantial variation in U5MR in all six countries: there was more than a two-fold difference in U5MR between the area with the highest rate and the area with the lowest rate in every country. All areas in all countries experienced declines in U5MR between 1980 and 2015, but the degree varied both within and between countries. In Cameroon, Chad, Mozambique, and Zambia we found areas with U5MRs in 2015 that were higher than in other parts of the same country in 1980. Comparing subnational U5MR to country-level targets for the Millennium Development Goals (MDG), we find that 12.8% of areas in Bangladesh did not meet the country-level target, although the country as whole did. A minority of areas in Chad, Mozambique, Uganda, and Zambia met the country-level MDG targets while these countries as a whole did not.Conclusions
Subnational estimates of U5MR reveal significant within-country variation. These estimates could be used for identifying high-need areas and positive deviants, tracking trends in geographic inequalities, and evaluating progress towards international development targets such as the Sustainable Development Goals.73.
Leventhal L Smith V Hornby G Andree TH Brandt MR Rogers KE 《The Journal of pharmacology and experimental therapeutics》2007,320(3):1178-1185
There is increasing recognition that norepinephrine (NE) and serotonin (5-HT) reuptake inhibitors (NRIs and SRIs) are efficacious in treating some types of pain. To date, studies have not systematically evaluated the relative activity at the NE and/or 5-HT transporter required for maximal efficacy in rodent pain models. Known selective NE and 5-HT reuptake inhibitors reboxetine, desipramine, fluoxetine, and paroxetine were evaluated in both in vitro and in vivo assays. Using the spinal nerve ligation model of neuropathic pain, the compounds differentially reversed tactile allodynia. Evaluation of a broader spectrum of reuptake inhibitors in the para-phenylquinone (PPQ)-induced abdominal constriction model, a model of acute visceral pain, demonstrated that both the SRIs and the NRIs significantly blocked abdominal constrictions. However, the magnitude of this effect was greater following treatment with compounds having greater affinity for NRI compared with SRI affinity. In addition, isobolographic analyses indicated significant synergistic effects for all combinations of desipramine and fluoxetine in the PPQ model of visceral pain. Collectively, the present results support the hypothesis that compounds with greater NRI activity should be more effective for the treatment of pain than compounds having only SRI activity, and this hypothesis is also supported by clinical data. These studies also suggest that the potency and effectiveness of NRIs might be enhanced by the presence of 5-HT activity. 相似文献
74.
Gary R. Schooler Juan C. Infante Michael Acord Adina Alazraki Govind B. Chavhan James Christopher Davis Geetika Khanna Ajaykumar C. Morani Cara E. Morin HaiThuy N. Nguyen Mitchell A. Rees Raja Shaikh Abhay Srinivasan Judy H. Squires Elizabeth Tang Paul G. Thacker Alexander J. Towbin 《Pediatric blood & cancer》2023,70(Z4):e29965
Primary hepatic malignancies are relatively rare in the pediatric population, accounting for approximately 1%–2% of all pediatric tumors. Hepatoblastoma and hepatocellular carcinoma are the most common primary liver malignancies in children under the age of 5 years and over the age of 10 years, respectively. This paper provides consensus-based imaging recommendations for evaluation of patients with primary hepatic malignancies at diagnosis and follow-up during and after therapy. 相似文献
75.
Judy H. Squires Claudia Martinez-Rios James C. Davis Kelly R. Dietz Monica S. Epelman Hollie A. Lai Jennifer E. Lim-Dunham Janice D. McDaniel Joyce C. Mhlanga Neeta Pandit-Taskar Marguerite T. Parisi Andrew T. Trout Elizabeth K. Weidman Adina L. Alazraki 《Pediatric blood & cancer》2023,70(Z4):e29957
Pediatric thyroid cancer is rare in children; however, incidence is increasing. Papillary thyroid cancer and follicular thyroid cancer are the most common subtypes, comprising about 90% and 10% of cases, respectively. This paper provides consensus imaging recommendations for evaluation of pediatric patients with thyroid cancer at diagnosis and during follow-up. 相似文献
76.
Danielle A. Bischof MD Yuhree Kim MD MPH Rebecca Dodson MD M. Carolina Jimenez Ramy Behman MD Andrei Cocieru MD Dan G. Blazer III FACS MD Sarah B. Fisher MD Malcolm H. Squires III MD MS David A. Kooby MD Shishir K. Maithel MD FACS Ryan T. Groeschl MD T. Clark Gamblin MD FACS Todd W. Bauer MD FACS Paul J. Karanicolas MD PhD Calvin Law MD MPH Fayez A. Quereshy MD MBA Timothy M. Pawlik MD MPH PhD FACS 《Annals of surgical oncology》2014,21(9):2941-2948
Background
Gastrointestinal stromal tumors (GIST) are the most common mesenchymal tumors of the gastrointestinal tract. Overall surgical experience with minimally invasive surgery (MIS) has increased; however, published reports on MIS resection of GIST are limited to small, single-institution experiences.Methods
A total of 397 patients who underwent open surgery (n = 230) or MIS (n = 167) for a gastric GIST between 1998 and 2012 were identified from a multicenter database. The impact of MIS approach on recurrence and survival was analyzed using propensity-score matching by comparing clinicopathologic factors between patients who underwent MIS versus open resection.Results
There were 19 conversions (10 %) to open; the most common reasons for conversion were tumor more extensive than anticipated (26 %) and unclear anatomy (21 %). On multivariate analysis, smaller tumor size and higher body mass index (BMI) were associated with receipt of MIS. In the propensity-matched cohort (n = 248), MIS resection was associated with decreased length of stay (MIS, 3 days vs open, 8 days) and fewer ≥ grade 3 complications (MIS, 3 % vs open, 14 %) compared with open surgery. High rates of R0 resection and low rates of tumor rupture were seen in both groups. After propensity-score matching, there was no difference in recurrence-free or overall survival comparing the MIS and the open group (both p > 0.05).Conclusions
An MIS approach for gastric GIST was associated with low morbidity and a high rate of R0 resection. The long-term oncological outcome following MIS was excellent, and therefore the MIS approach should be considered the preferred approach for gastric GIST in well-selected patients. 相似文献77.
Philippe Lagac-Wiens Claire Sevenhuysen Liza Lee Andrea Nwosu Tiffany Smith 《传染性疾病的发现RMTC(加拿大)》2021,47(3):142
BackgroundThe first coronavirus disease 2019 (COVID-19) case was reported in Canada on January 25, 2020. In response to the imminent outbreak, many provincial and territorial health authorities implemented nonpharmaceutical public health measures to curb the spread of disease. “Social distancing” measures included restrictions on group gatherings; cancellation of sports, cultural and religious events and gatherings; recommended physical distancing between people; school and daycare closures; reductions in non-essential services; and closures of businesses.ObjectivesTo evaluate the impact of the combined nonpharmaceutical interventions imposed in March 2020 on influenza A and B epidemiology by comparing national laboratory surveillance data from the intervention period with 9-year historical influenza season control data.MethodsWe obtained epidemiologic data on laboratory influenza A and B detections and test volumes from the Canadian national influenza surveillance system for the epidemiologic period December 29, 2019 (epidemiologic week 1) through May 2, 2020 (epidemiologic week 18). COVID-19-related social distancing measures were implemented in Canada from epidemiologic week 10 of this period. We compared influenza A and B laboratory detections and test volumes and trends in detection during the 2019–20 influenza season with those of the previous nine influenza seasons for evidence of changes in epidemiologic trends.ResultsWhile influenza detections the week prior to the implementation of social distancing measures did not differ statistically from the previous nine seasons, a steep decline in positivity occurred between epidemiologic weeks 10 and 14 (March 8–April 4, 2020). Both the percent positive on week 14 (p≤0.001) and rate of decline between weeks 10 and 14 (p=0.003) were significantly different from mean historical data.ConclusionThe data show a dramatic decrease in influenza A and B laboratory detections concurrent with social distancing measures and nonpharmaceutical interventions in Canada. The impact of these measures on influenza transmission may be generalizable to other respiratory viral illnesses during the study period, including COVID-19. 相似文献
78.
Diana Leticia Coronel-MartÍnez Juliana Park Eduardo López-Medina María Rosario Capeding Andrés Angelo Cadena Bonfanti María Cecilia Montalbán Isabel Ramírez María Liza Antoinette Gonzales Carlos A DiazGranados Betzana Zambrano Gustavo Dayan Stephen Savarino Zhenghong Chen Hao Wang Sunny Sun Matthew Bonaparte Andrey Rojas Jenny Carolina Ramírez Fernando Noriega 《The Lancet infectious diseases》2021,21(4):517-528
79.
Wohl AR Lu S Turner J Kovacs A Witt M Squires K Towner W Beer V 《AIDS patient care and STDs》2003,17(6):267-275
There are few studies that compare opportunistic infection (OI) rates for U.S.-born, Mexican-born, and Central American-born Latinos in the pre- or post-highly active antiretroviral therapy (HAART) era. Data on 803 Latino persons in treatment for HIV infection in Los Angeles, California, were examined to evaluate differences in risk for specific and total OIs by country of origin. In a Cox proportional hazards regression analysis that controlled for HAART use, CD4 counts, and age, U.S.-born Latino women were more likely than Central American-born Latino women to develop an OI from 1996 to 2000 (hazard ratio [HR] = 2.9, 95% confidence intervals [CIs]: 1.3, 6.5). In a Poisson regression analysis, U.S.-born Latino men and women combined were at greater risk for HIV encephalopathy (RR = 3.4, 95% CIs: 1.2, 10.0) and Kaposi's sarcoma (RR = 2.9, 95% CIs: 1.1, 7.6). In addition to underreporting that may result from the use of English-based criteria for diagnosing HIV encephalopathy among Spanish-speaking patients, these HAART era data suggest that variation in OI risk among Latinos may also be explained by acculturation factors, such as loss of social support systems and negative lifestyle changes. 相似文献
80.